Newsletter

NY, NJ regulators compare experiences with unregulated shops • NIDA’s new prevention clinical trial • & more …

An excerpt from a recent edition of the Cannabis Wire Daily newsletter.

Research

NIDA Welcomes Proposals From New Cannabis Suppliers

Today, seven entities meet the basic criteria to compete for a contract to supply the National Institute on Drug Abuse with research-grade cannabis, and it could be worth up to $25 million.

Caribbean

In Trinidad and Tobago, Medical Cannabis Clears a Major Hurdle

The House of Representatives passed a bill, years in the making, to legalize and regulate cannabis for medical and religious purposes.